This is a profile image of Dr. Sarun Charumilind

Dr. Sarun Charumilind

Supports the design and delivery of high-quality, efficient, accessible healthcare that generates the best possible individual and population outcomes through clinically driven, healthcare-value strategy and analytics

Sarun is a leader in McKinsey’s Healthcare, Public Sector, and Social Sector Practices, focused on transforming healthcare to generate high-quality, efficient, and accessible care and achieve the best possible individual and population outcomes. He coleads the healthcare innovation domain and leads the firm's network, care delivery, and payment innovation efforts across the healthcare value chain.

Sarun supports a broad range of organizations, including private and public payers, providers, investors, technology innovators, government agencies, and foundations. He tackles healthcare and public-health challenges through clinically-driven, data-backed strategy and analytics, and through his leadership of multidisciplinary teams of generalist consultants, advanced analytics practitioners, and technologists.

Sarun also leads the firm’s global COVID-19 epidemiology capability and has led the firm’s support to clients and society to combat the opioid crisis. During the pandemic, Sarun has supported hundreds of public, social, and private sector organizations globally to apply epidemiology and public health to strategy and business planning.

Published work

How price transparency could affect US healthcare markets,” McKinsey & Company, April 2024

One billion days lost: How COVID-19 is hurting the US workforce,” McKinsey & Company, January 2023

When will the COVID-19 pandemic end?,” McKinsey & Company, July 2022

When will the COVID-19 pandemic end?,” McKinsey & Company, March 2022

When will the COVID-19 pandemic end?,” McKinsey & Company, December 2021

Pandemic to endemic: How the world can learn to live with COVID-19,” McKinsey & Company, October 2021

COVID-19: A comparison with other public-health burdens,” McKinsey & Company, September 2021

When will the COVID-19 pandemic end?,” McKinsey & Company, August 2021

When will the COVID-19 pandemic end?,” McKinsey & Company, March 2021

All in the mix: Why US COVID-19 cases rose and fell, and what comes next,” McKinsey & Company, March 2021

When will the COVID-19 pandemic end?,” McKinsey & Company, January 2021

When will the COVID-19 pandemic end?,” McKinsey & Company, November 2020

When will the COVID-19 pandemic end?,” McKinsey & Company, September 2020

Preventing future waves of COVID-19,” McKinsey & Company, August 2020

COVID-19: Saving thousands of lives and trillions in livelihoods,” McKinsey & Company, August 2020

Demystifying modeling: How quantitative models can—and can’t—explain the world,” McKinsey & Company, June 2020

Maximizing the value in value networks and value based payment,” McKinsey & Company, April 2019 

Why we need bolder action to combat the opioid epidemic,” McKinsey & Company, September 2018

Ten insights on the US opioid crisis from claims data analysis,” McKinsey & Company, June 2018

Past experience

Massachusetts General Hospital
Attending physician, General Medicine Unit and Chelsea HealthCare Center Urgent Care
Resident, Primary Care and Internal Medicine

Harvard University
Researcher, Global Health Delivery Project 

Health in Harmony
Teaching physician, Indonesia

Education

Harvard University
MD
BA, history and science

London School of Hygiene & Tropical Medicine
MSc, public health in developing countries